Holocene Advisors’s ResMed RMD Stock Holding History

Holocene Advisors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-441,396	Closed	-$96.4M	–	859
2023 Q2	$96.4M	Sell	441,396 -210,816	-32%	-$47M	0.41%	81
2023 Q1	$143M	Buy	652,212 +650,133	+31,271%	+$141M	0.7%	37
2022 Q4	$433K	Buy	+2,079	New	+$457K	﹤0.01%	633
2022 Q3	–	Sell	-26,512	Closed	-$5.56M	–	927
2022 Q2	$5.56M	Buy	+26,512	New	+$5.64M	0.03%	316
2021 Q3	–	Sell	-11,319	Closed	-$2.79M	–	950
2021 Q2	$2.79M	Sell	11,319 -7,018	-38%	-$1.48M	0.02%	484
2021 Q1	$3.56M	Buy	+18,337	New	+$3.68M	0.02%	465
2019 Q3	–	Sell	-6,927	Closed	-$845K	–	828
2019 Q2	$845K	Sell	6,927 -923	-12%	-$102K	0.01%	325
2019 Q1	$816K	Sell	7,850 -3,425	-30%	-$354K	0.01%	296
2018 Q4	$1.28M	Buy	11,275 +1,045	+10%	+$112K	0.02%	216
2018 Q3	$1.18M	Buy	+10,230	New	+$1.12M	0.02%	229
2018 Q1	–	Sell	-6,199	Closed	-$525K	–	693
2017 Q4	$525K	Buy	+6,199	New	+$512K	0.01%	399

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Holocene Advisors's RMD Position: Q3 2023 in Review

Holocene Advisors sold out of ResMed (RMD) in Q3 2023, closing a stake of 441,396 shares — an estimated $96.4M sold.

Holocene Advisors first reported a position in RMD in Q4 2017 and held it in 11 quarters. The position peaked at $143M in Q1 2023. 657 funds tracked by Wall St. Rank hold RMD as of Q3 2023.

Holocene Advisors reported no remaining ResMed position as of Q3 2023 after selling out during the quarter.
Holocene Advisors sold 441,396 ResMed shares in Q3 2023, an estimated $96.4M.
Holocene Advisors first reported a position in ResMed in Q4 2017 and held it in 11 quarters.
Holocene Advisors's ResMed position peaked at $143M in Q1 2023.
657 funds tracked by Wall St. Rank held ResMed as of Q3 2023.

Based on Holocene Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.